TSN 0.00% 1.0¢ the sustainable nutrition group ltd

Analysis of 1st quarter results:Dr Reddy's said its growth in...

  1. 486 Posts.
    lightbulb Created with Sketch. 71
    Analysis of 1st quarter results:

    Dr Reddy's said its growth in North America was largely driven by new product launches of clopidogrel, over-the-counter lansoprazole, and was further supported by key products like ziprasidone, fondaparinux, quetiapine, etc, marginally offset by regular year-on-year price declines in existing product basket.

    http://www.moneycontrol.com/news/results/dr-reddys-labs-q1-disappoints-net28-at-rs-336-cr_732637.html
 
watchlist Created with Sketch. Add TSN (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.